China Pharma Holdings, Inc. (CPHI) stock
CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
$0.54−0.01 (-1.43%)
Close on Nov 11, 2026Market cap $23.37MP/E –Yield –
China Pharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
China Pharma's price to sales ratio was 5.6× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.7× to 23.6×, with a median of 5.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.6× | +4.6 |
| 2025 | Dec 31, 2025 | 1.0× | −6.5 |
| 2024 | Dec 31, 2024 | 7.5× | +3.1 |
| 2023 | Dec 29, 2023 | 4.4× | −1.8 |
| 2022 | Dec 30, 2022 | 6.2× | −17.3 |
| 2021 | Dec 31, 2021 | 23.6× | +5.7 |
| 2020 | Dec 31, 2020 | 17.9× | +8.6 |
| 2019 | Dec 31, 2019 | 9.3× | +0.6 |
| 2018 | Dec 31, 2018 | 8.7× | +3.4 |
| 2017 | Dec 29, 2017 | 5.2× | −2.4 |
| 2016 | Dec 30, 2016 | 7.6× | +4.0 |
| 2015 | Dec 31, 2015 | 3.6× | −1.2 |
| 2014 | Dec 31, 2014 | 4.8× | +0.6 |
| 2013 | Dec 31, 2013 | 4.2× | +2.9 |
| 2012 | Dec 31, 2012 | 1.3× | −2.2 |
| 2011 | Dec 30, 2011 | 3.5× | – |
See a number that looks wrong?